RYTM Rhythm Pharmaceuticals
Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.
$21.25 -0.42 (-1.94%)
As of 04/09/2021 15:59:52 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Small cap
GICS sector: Health Care
Industry: Biotechnology
Index country: USA
Country of incorporation: USA
IPO date: 10/05/2017
Outstanding shares: 50,181,164
Average volume: 520,357
Market cap: $1,067,353,358
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
CUSIP: 76243J105
ISIN: US76243J1051
Sedol: BF2YWG4
Valuation (See tab for details)
PE ratio: 0.00
PB ratio: 5.65
PS ratio: 0.00
Return on equity: -80.46%
Net income %: 0.00%